Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Oct 24 | CAMP4 Therapeutics | Common Stock | Buy | Acquire P | Yes | No | 11 | 909,090 | 10.00 mm | 2,625,145 |
15 Oct 24 | CAMP4 Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 302,770 | 0.00 | 302,770 |
15 Oct 24 | CAMP4 Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 1,716,055 | 0.00 | 1,716,055 |
15 Oct 24 | CAMP4 Therapeutics | Series B Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 3,395,816 | 0.00 | 0 |
15 Oct 24 | CAMP4 Therapeutics | Series B Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,244,770 | 0.00 | 0 |
15 Oct 24 | CAMP4 Therapeutics | Series A Prime Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 15,002,166 | 0.00 | 0 |
13 Sep 24 | SKYE Skye Bioscience | Common Stock | Sell | Dispose S | Yes | No | 6.06 | 79 | 478.74 | 66,277 |
13 Sep 24 | SKYE Skye Bioscience | Common Stock | Sell | Dispose S | Yes | No | 6.06 | 2,000 | 12.12 k | 1,679,685 |
13 Sep 24 | SKYE Skye Bioscience | Common Stock | Sell | Dispose S | Yes | No | 6.06 | 11,758 | 71.25 k | 8,167,206 |
11 Sep 24 | SKYE Skye Bioscience | Common Stock | Sell | Dispose S | Yes | No | 6.6 | 1,440 | 9.50 k | 66,356 |